C.H. Robinson (CHRW)

Nasdaq Industrials Air Freight & Logistics S&P 500
$125.33
-2.98 (-2.32%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+0.6%
1M-11.3%
3M-15.5%
6M-26.9%
YTD-22.0%
1Y-18.1%
3Y+53.9%
5Y+29.2%

Key statistics

Full financials →
Market cap$14.5B
P/E (TTM)22.5
EPS (TTM, diluted)$5.57
P/S0.80
P/B9.20
EV / EBITDA16.5
Revenue (TTM)$18.22B
Revenue growth+10.4%
Net margin3.7%
ROE42.3%
Debt / equity1.18
FCF yield3.6%
Dividend yield2.01%
Payout ratio45%
Beta (1Y)0.72
Volatility (1Y)45.1%
52-week range$122.21 – $210.33
Avg volume (50D)1.86M

Revenue & net income — last 8 quarters

Statements →

Chart pattern: Falling Wedge (weekly)

Forming
CHRW Falling Wedge chart

Trigger $141.10 (+12.6% away). Details →

Nov 4, 4:05 PM ET

C.H. Robinson amends credit agreement and note purchase agreement, dated November 2, 2026

Neutral financing 1.012.03

C.H. Robinson Worldwide disclosed amendments dated November 2, 2026, to its existing credit agreement with U.S. Bank National Association as administrative agent and to its note purchase agreement with noteholders. The filing does not state new borrowing amounts, interest rates or maturities, so the size and terms of the changes cannot be determined from this document.

  • Sixth Omnibus Amendment, dated November 2, 2026, amends a credit agreement originally dated October 29, 2012, with U.S. Bank National Association as administrative agent.
  • Fourth Amendment to Note Purchase Agreement, dated November 2, 2026, was entered into with noteholders and guarantors.
  • Certain schedules and exhibits were omitted under Item 601(a)(5) of Regulation S-K and will be provided to the SEC on request.
Read the filing on SEC.gov ↗
Oct 28, 8:03 AM ET

C.H. Robinson Q3 diluted EPS rises 24.6% to $1.67 on 29.5% revenue growth to $5.4 billion

Positive earnings 1.012.02

C.H. Robinson reported third-quarter 2026 results with total revenues up 29.5% to $5.4 billion, income from operations up 23.1% to $271.8 million, and diluted EPS up 24.6% to $1.67. Operating cash flow fell $151.3 million to $124.1 million, which the company attributed to higher working capital needs driven by higher transportation rates. The filing also discloses a Fifth Amendment to its credit agreement dated October 22, 2026, and refers to a proposed acquisition of RXO, Inc. whose terms the filing does not detail.

  • Diluted EPS of $1.67, up 24.6%; adjusted diluted EPS of $1.80, up 28.6%
  • Total revenues of $5.4 billion, up 29.5%; net income of $198.5 million, up 21.8%
  • Cash generated by operations fell $151.3 million to $124.1 million, driven by a $267.4 million sequential increase in net operating working capital
  • Fifth Amendment to the credit agreement dated October 22, 2026, with U.S. Bank National Association as administrative agent
Read the filing on SEC.gov ↗
Oct 5, 8:20 AM ET

C.H. Robinson to acquire RXO in $5.8 billion stock-and-cash deal

Mixed m&a Written later 1.017.01

C.H. Robinson agreed on October 4, 2026 to acquire RXO through a merger that the companies value at an implied $5.8 billion. RXO shareholders can elect $17.25 in cash plus 0.0856 C.H. Robinson shares, $30.25 in cash, or 0.1992 C.H. Robinson shares, with proration targeting about 57% cash and 43% stock. The deal is expected to close in the first half of 2027 and requires RXO stockholder approval and regulatory clearance, and C.H. Robinson expects about $300 million of net run-rate cost synergies within two years of closing.

  • Implied value of $5.8 billion; RXO shareholders would own about 11% of the combined company
  • Expected net run-rate cost synergies of about $300 million within two years after closing
  • C.H. Robinson will fund the cash portion with new debt and has a bridge facility from Morgan Stanley Senior Funding; it plans to pause share repurchases until reaching its target leverage
  • RXO would pay a $175 million termination fee in certain circumstances; the outside date is July 4, 2027, subject to two three-month extensions
Read the filing on SEC.gov ↗
Jul 29, 4:36 PM ET

C.H. Robinson Q2 diluted EPS rises 23.8% to $1.56 on 19.3% revenue gain

Positive earnings Written later 2.02

C.H. Robinson reported second-quarter 2026 results for the quarter ended June 30, 2026. Total revenues rose 19.3% to $4.9 billion, diluted EPS rose 23.8% to $1.56, and income from operations rose 18.4% to $255.7 million. Cash generated by operations fell $191.2 million to $35.9 million, mainly because of a rise in net operating working capital, while cash returned to shareholders increased 87.5% to $301.3 million.

  • Total revenues increased 19.3% to $4.9 billion, primarily driven by higher pricing in truckload, LTL, air and ocean services.
  • Diluted EPS was $1.56, up 23.8%; adjusted diluted EPS was $1.61, up 24.8%.
  • Cash generated by operations was $35.9 million, down $191.2 million from $227.1 million a year earlier.
  • Cash returned to shareholders totaled $301.3 million, including $226.0 million in stock repurchases and $75.3 million in dividends.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own CHRW

All investors →
InvestorValue% of portfolioLast quarter
Ray Dalio Bridgewater Associates $12.77M0.05% Added

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All CHRW congressional trades →
TradedMemberTypeAmount
Aug 25, 2026April McClain Delaney MD-06Sell$100,001 – $250,000
Aug 14, 2026April McClain Delaney MD-06Buy$1,001 – $15,000
Aug 12, 2026April McClain Delaney MD-06Buy$1,001 – $15,000
Aug 03, 2026April McClain Delaney MD-06Buy$15,001 – $50,000
Jul 31, 2026April McClain Delaney MD-06Buy$15,001 – $50,000
Jul 28, 2026April McClain Delaney MD-06Buy$1,001 – $15,000
Jul 27, 2026April McClain Delaney MD-06Buy$15,001 – $50,000
Jul 24, 2026April McClain Delaney MD-06Buy$1,001 – $15,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Prices are end-of-day and split-adjusted. Financial data from C.H. Robinson's SEC XBRL filings. Not investment advice.